Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-22-024501

Director sold 25,041 shares at an average $23.58 ($590,451)

  • Director acquired 25,041 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Heffernan Michael Thomas · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-22 Exercise or conversion : show line 1 in the form +237 $16.15 $3,828 28,260 D
2022-12-22 Sale : show line 2 in the form −237 $23.00 $5,451 28,023 D
2022-12-23 Exercise or conversion : show line 3 in the form +4,989 $16.15 $80,572 33,012 D
2022-12-23 Sale : show line 4 in the form −4,989 $23.00 $114,747 28,023 D
2022-12-27 Exercise or conversion : show line 5 in the form +15,995 $16.15 $258,319 44,018 D
2022-12-27 Sale : show line 6 in the form −15,995 $23.63 $377,962 28,023 D
2022-12-27 Exercise or conversion : show line 7 in the form +3,820 $16.15 $61,693 31,843 D
2022-12-27 Sale : show line 8 in the form −3,820 $24.16 $92,291 28,023 D
Open-market sales · 25,041 sh · avg $23.58 · $590,451

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2022-12-22 Exercise or conversion : show line 9 in the form Stock Option (Right to Purchase) −237 24,804 D
2022-12-23 Exercise or conversion : show line 10 in the form Stock Option (Right to Purchase) −4,989 19,815 D
2022-12-27 Exercise or conversion : show line 11 in the form Stock Option (Right to Purchase) −15,995 3,820 D
2022-12-27 Exercise or conversion : show line 12 in the form Stock Option (Right to Purchase) −3,820 0 D
Loading xslF345X03/form4.xml…